Replies to post #29707 on Ocata Therapeutics Inc fka OCAT

[Lil' Jon]

The patent overcomes the moral/ethical concerns of murdering an embryo to obtain esc's. It is a non-event in trading town.

[cty]

I emailed a reporter who covers bio technology sector at the NY Times with a link to the press release regarding the blastomere patent. He responded to me early this morning , thanking me for making him aware of the news. So hopefully we may see an article regarding this patent. It is a tremendous accomplishment and should generate some very nice revenues for ACTC in the near future.